Today the Cellceutix Corporation announced that its new anti-cancer drug candidate Kevetrin will soon be entering clinical trials at the Harvard Cancer Center's Dana-Farber Cancer...
Two phase 3 clinical trials have shown that oral doses of a drug called BG-12 show "significant" and "clinically meaningful" reductions in multiple sclerosis (MS) relapses and brai...
The U.S. FDA this week approved a once-a-day pill for the treatment of multiple sclerosis (MS). The pill, being branded as "Aubagio" by Sanofi S.A., is specifically for the treatm...
Pfizer this week announced that Bosulif, a medication it developed for the treatment of a rare type of Leukemia, has been approved by the U.S. Food and Drug Administration.
The...
A study by the Group Health Research Institute in Seattle has determined that trastuzumab, the drug behind the brand name Herceptin, raises the risks for heart problems in breast c...
Google Inc. has until the 9th of April to give the Dekalb County Pension Fund investors company documents involving what authorities said was the illegal online marketing of prescr...
WebProNews is an iEntry Publication
